These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 22957298)

  • 1. Microglia, Alzheimer's disease, and complement.
    Crehan H; Hardy J; Pocock J
    Int J Alzheimers Dis; 2012; 2012():983640. PubMed ID: 22957298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4 Cross-Talk With NLRP3 Inflammasome and Complement Signaling Pathways in Alzheimer's Disease.
    Yang J; Wise L; Fukuchi KI
    Front Immunol; 2020; 11():724. PubMed ID: 32391019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active immunization against complement factor C5a: a new therapeutic approach for Alzheimer's disease.
    Landlinger C; Oberleitner L; Gruber P; Noiges B; Yatsyk K; Santic R; Mandler M; Staffler G
    J Neuroinflammation; 2015 Aug; 12():150. PubMed ID: 26275910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRP1 modulates the microglial immune response via regulation of JNK and NF-κB signaling pathways.
    Yang L; Liu CC; Zheng H; Kanekiyo T; Atagi Y; Jia L; Wang D; N'songo A; Can D; Xu H; Chen XF; Bu G
    J Neuroinflammation; 2016 Dec; 13(1):304. PubMed ID: 27931217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pro-inflammatory cytokines in Alzheimer's disease].
    Stamouli EC; Politis AM
    Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TREM2-Dependent Effects on Microglia in Alzheimer's Disease.
    Zhou Y; Ulland TK; Colonna M
    Front Aging Neurosci; 2018; 10():202. PubMed ID: 30038567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia.
    Tsai AP; Lin PB; Dong C; Moutinho M; Casali BT; Liu Y; Lamb BT; Landreth GE; Oblak AL; Nho K
    Neurobiol Dis; 2021 Jun; 153():105303. PubMed ID: 33631273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Veerhuis R; Janssen I; De Groot CJ; Van Muiswinkel FL; Hack CE; Eikelenboom P
    Exp Neurol; 1999 Nov; 160(1):289-99. PubMed ID: 10630213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease.
    Ager RR; Fonseca MI; Chu SH; Sanderson SD; Taylor SM; Woodruff TM; Tenner AJ
    J Neurochem; 2010 Apr; 113(2):389-401. PubMed ID: 20132482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures.
    Lue LF; Walker DG; Rogers J
    Neurobiol Aging; 2001; 22(6):945-56. PubMed ID: 11755003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic stress as a risk factor for Alzheimer's disease: Roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress.
    Bisht K; Sharma K; Tremblay MÈ
    Neurobiol Stress; 2018 Nov; 9():9-21. PubMed ID: 29992181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglia in Alzheimer's disease.
    Hansen DV; Hanson JE; Sheng M
    J Cell Biol; 2018 Feb; 217(2):459-472. PubMed ID: 29196460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockage of CR1 prevents activation of rodent microglia.
    Crehan H; Hardy J; Pocock J
    Neurobiol Dis; 2013 Jun; 54():139-49. PubMed ID: 23454195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer's disease.
    Kaur D; Sharma V; Deshmukh R
    Inflammopharmacology; 2019 Aug; 27(4):663-677. PubMed ID: 30874945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement and microglia mediate early synapse loss in Alzheimer mouse models.
    Hong S; Beja-Glasser VF; Nfonoyim BM; Frouin A; Li S; Ramakrishnan S; Merry KM; Shi Q; Rosenthal A; Barres BA; Lemere CA; Selkoe DJ; Stevens B
    Science; 2016 May; 352(6286):712-716. PubMed ID: 27033548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease.
    Rangaraju S; Dammer EB; Raza SA; Rathakrishnan P; Xiao H; Gao T; Duong DM; Pennington MW; Lah JJ; Seyfried NT; Levey AI
    Mol Neurodegener; 2018 May; 13(1):24. PubMed ID: 29784049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice.
    Shi Q; Chowdhury S; Ma R; Le KX; Hong S; Caldarone BJ; Stevens B; Lemere CA
    Sci Transl Med; 2017 May; 9(392):. PubMed ID: 28566429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement receptor 1 is expressed on brain cells and in the human brain.
    Daskoulidou N; Shaw B; Torvell M; Watkins L; Cope EL; Carpanini SM; Allen ND; Morgan BP
    Glia; 2023 Jun; 71(6):1522-1535. PubMed ID: 36825534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple inflammatory profiles of microglia and altered neuroimages in APP/PS1 transgenic AD mice.
    Liu L; Liu Y; Li N; Huang R; Zheng X; Huang L; Hou S; Yuan Q
    Brain Res Bull; 2020 Mar; 156():86-104. PubMed ID: 31931120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.